Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of SABIN monovalent oral polio vaccine type 2 in IPV-vaccinated children in Lithuania
2015-003544-39Phase 4Completed
- Sponsor
- Fighting Infectious Diseases in Emerging Countries
- Start
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of m-OPV2 in poliomyelitis, sponsored by Fighting Infectious Diseases in Emerging Countries. Started Sep 2015; status: completed.
02
Drugs
m-OPV2
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2015-003544-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003544-39.